Search for another bill
Search for another bill or initiative
HB 2710 - 2019-20
Modifying the uses, disclosure, and requirement dates of prescription drug price transparency data.
Bill history
2020 Regular Session
In the House
Jan 20
First reading, referred to Health Care & Wellness.
(View original bill)
Jan 29
Public hearing in the House Committee on Health Care & Wellness at 1:30 PM.
(Committee materials)
Feb 4
Executive action taken in the House Committee on Health Care & Wellness at 1:30 PM.
(Committee materials)
HCW - Majority; do pass.
(Majority report)
Feb 6
Referred to Rules 2 Review.
Feb 16
Rules Committee relieved of further consideration. Placed on second reading.
Feb 17
Rules suspended. Placed on Third Reading.
Third reading, passed; yeas, 56; nays, 42; absent, 0; excused, 0.
(View this roll call)
In the Senate
Feb 19
First reading, referred to Health & Long Term Care.
Feb 28
Public hearing and executive session scheduled, but no action was taken in the Senate Committee on Health & Long Term Care at 8:00 AM.
(Committee materials)
Mar 12
By resolution, returned to House Rules Committee for third reading.
Available documents
For a complete list of documents, go to Detailed Legislative Reports Text of a legislative document.
Fiscal note
Amendments
Available videos